Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Alain Couvineau"'
Autor:
Alain Couvineau, Cécile Haumaitre
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4361 (2024)
Inflammatory diseases commonly associated with humans are chronic inflammatory gastrointestinal diseases (CIGDs) [...]
Externí odkaz:
https://doaj.org/article/d2cf320ed9c64c74a8a64d0ce3b69edc
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/6bc1026b05ee4d78bcc985b3410d62e2
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
At the end of the 20th century, two new neuropeptides (Orexin-A/hypocretin-1 and Orexin-B/hypocretins-2) expressed in hypothalamus as a prepro-orexins precursor, were discovered. These two neuropeptides interacted with two G protein-coupled receptor
Externí odkaz:
https://doaj.org/article/7c1ebcc397be4763952562d1e60eb4d5
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9554 (2023)
Inflammatory bowel diseases are chronic inflammation of the intestinal mucosa characterized by relapsing–remitting cycle periods of variable duration. Infliximab (IFX) was the first monoclonal antibody used for the treatment of Crohn’s disease an
Externí odkaz:
https://doaj.org/article/6268771979bc4004ba45da52d4f57aec
Autor:
Thierry Voisin, Pascal Nicole, Valérie Gratio, Anaïs Chassac, Dounia Mansour, Vinciane Rebours, Anne Couvelard, Alain Couvineau
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Pancreatic ductal adenocarcinoma (PDAC) represents the fourth cause of cancer-associated death in the West. This type of cancer has a very poor prognosis notably due to the development of chemoresistance when treatments including gemcitabine and Abra
Externí odkaz:
https://doaj.org/article/c0af87ddb808446da691e04604091bcb
Autor:
Laurine Becquet, Catalina Abad, Mathilde Leclercq, Camille Miel, Laetitia Jean, Gaëtan Riou, Alain Couvineau, Olivier Boyer, Yossan-Var Tan
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-12 (2019)
Abstract Background Orexins (hypocretins, Hcrt) A and B are GPCR-binding hypothalamic neuropeptides known to regulate sleep/wake states and feeding behavior. A few studies have shown that orexin A exhibits anti-inflammatory and neuroprotective proper
Externí odkaz:
https://doaj.org/article/69e7f6833b604226b92795a7fa86ab95
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 406 (2022)
Homeostasis of the human immune system is regulated by many cellular components, including two neuropeptides, VIP and PACAP, primary stimuli for three class B G protein-coupled receptors, VPAC1, VPAC2, and PAC1. Vasoactive intestinal peptide (VIP) an
Externí odkaz:
https://doaj.org/article/3db98cf729464ea09b01c6a6713c0dcc
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/1bd985dc373c40d6ab8f3b091b6c92b9
Autor:
Alain Couvineau, Thierry Voisin, Pascal Nicole, Valérie Gratio, Catalina Abad, Yossan-Var Tan
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
Orexins [orexin-A (OXA) and orexin-B (OXB)] are two isoforms of neuropeptides produced by the hypothalamus. The main biological actions of orexins, focused on the central nervous system, are to control the sleep/wake process, appetite and feeding, en
Externí odkaz:
https://doaj.org/article/55e838f08bc74dd0a121eb5d2f8ea50e
Autor:
Alain Couvineau, Stéphanie Dayot, Pascal Nicole, Valérie Gratio, Vinciane Rebours, Anne Couvelard, Thierry Voisin
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Orexins (OxA and OxB) also termed hypocretins are hypothalamic neuropeptides involved in central nervous system (CNS) to control the sleep/wake process which is mediated by two G protein-coupled receptor subtypes, OX1R, and OX2R. Beside these central
Externí odkaz:
https://doaj.org/article/d74b4312804f40f282aa68359b48c113